Johnson & Johnson has dropped plans to develop its recently [...]

Analysis highlights potential for benefits far beyond obesity, signalling a [...]

Medable has launched Agent Studio, which it describes as the [...]

Swedish clinical-stage biotech Anocca AB has secured approximately SEK 440 [...]

IQVIA and Veeva Systems have announced the resolution of all [...]

Advarra, known for regulatory reviews and clinical research technology, has [...]

James Anderson is the Chair of the INTREPID Alliance and the Executive Director of Global Health at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), a leading global organization representing pharmaceutical companies. In his role at IFPMA, James spearheads efforts to address critical global health challenges, including antimicrobial resistance, pandemic preparedness, and non-communicable diseases.

Ethris has dosed the first patient in a Phase 2a [...]

New data presented at the Alzheimer’s Association International Conference 2025 [...]

A new investigational HIV vaccine candidate, GRAdHIVNE1, has entered Phase [...]